← All organizations

Shanghai Bovax Biotechnology Co., Ltd.

Government

Also known as: Chongqing Bovax Biopharmaceutical Co., Ltd. | Shanghai Bovax Biotechnology Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 15, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 10 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

15-valent recombinant human papillomavirus vaccine

Indications

Studied for

Recent trials (14)

NCT06756269Lead sponsorPhase 2Jan 15, 2025
NCT06454175Lead sponsorPhase 1Aug 3, 2024
NCT06465914Lead sponsorPhase 3Jul 11, 2024
NCT05584332Lead sponsorPhase 3Nov 15, 2022
NCT04895020Lead sponsorPhase 3May 28, 2021
NCT04895020CollaboratorPhase 3May 28, 2021
NCT05372016CollaboratorPhase 3Sep 19, 2020
NCT05372016Lead sponsorPhase 3Sep 19, 2020
NCT04425291CollaboratorPhase 3May 28, 2020
NCT04425291Lead sponsorPhase 3May 28, 2020
NCT04422366Lead sponsorPhase 3Apr 28, 2020
NCT03676101CollaboratorPhase 1Oct 8, 2018
NCT03676101Lead sponsorPhase 1Oct 8, 2018
NCT03085381Lead sponsorPhase 1Dec 1, 2016

Details

Last known activity: Jan 15, 2025